PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Viemed Healthcare, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Viemed Healthcare, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
  • Debt Due Cover Ratio: Debt due within a year is covered 47.6 times by its yearly operating cash. Higher than 95% of Healthcare companies in United States.
  • Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $374 of operating cash. Higher than 91% of Healthcare companies in United States.

Where $100 of sales goes

$92Operating costs$0.4Interest$5.5Net profit

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$374

Over the last 3 years, every $100 of reported profit came with $374 of operating cash.

Higher than 91% of Healthcare companies in United States.

Self-Funding Ratio

1.3×

Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.

Higher than 70% of Healthcare companies in United States.

Cash Locked Ratio

$5

For every $100 of sales, $5 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $7 tied up three years earlier.

Less money tied up than 88% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

$7

Sales grew 95% in 3 years; of every extra $100 of sales, $7 became extra profit.

Lower than 60% of Healthcare companies in United States.

Asset Productivity Ratio

+95% / +70%

In 3 years sales changed by +95% while total assets changed by +70%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

47.6×

Debt due within a year is covered 47.6 times by its yearly operating cash.

Higher than 95% of Healthcare companies in United States.

Cash Cushion Ratio

−1%

Debt, after subtracting cash, equals 1% of its market value (net debt).

Lower than 69% of Healthcare companies in United States.

Tangible Assets Ratio

70%

Of every $100 the company owns, $70 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 62% of Healthcare companies in United States.

Tangible Net Worth Ratio

57%

Of every $100 of net worth, $57 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 51% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Viemed Healthcare, Inc. owes $0.29 for every $1 it owns. Net profit rose 33% in the year to Dec 2025, and grew 34% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

27.6

Investors pay $27.6 for every $1 of Viemed Healthcare, Inc.'s yearly profit, higher than 52% of Healthcare companies in United States.

P/B ratio

2.62

The share price is 2.62 times Viemed Healthcare, Inc.'s book value per share, higher than 51% of Healthcare companies in United States.

Market cap

$378 M

The total market value of all of Viemed Healthcare, Inc.'s shares at today's price (share price × number of shares), larger than 51% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$144 M

What Viemed Healthcare, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$3.78

Net worth divided by the number of shares. The share price of $9.92 is 2.6 times this, which is the P/B above.

Return on equity (ROE)

10.4%

Viemed Healthcare, Inc. earned 10.4% on its shareholders' money over the last year, higher than 84% of Healthcare companies in United States.

Owes vs Owns

0.29×

Viemed Healthcare, Inc. owes $0.29 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.

Dividend yield

None

Viemed Healthcare, Inc. does not currently pay a dividend.

Revenue growth

+21%

Revenue rose 21% in the year to Dec 2025, and grew 25% a year on average over 3 years.

Profit growth

+33%

Net profit rose 33% in the year to Dec 2025, and grew 34% a year on average over 3 years.

Profit margin

5.5%

Viemed Healthcare, Inc. keeps $6 of every $100 of revenue as net profit.

Cash quality

3.5×

Cash from Viemed Healthcare, Inc.'s business was 3.5× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

17.5×

Viemed Healthcare, Inc.'s operating profit covered its interest costs 17.5 times in the year to Dec 2025.

Cash vs debt

Net debt

Viemed Healthcare, Inc. had $2 M more debt than cash (net debt) at Dec 2025.

Questions

What is Viemed Healthcare, Inc.'s P/E ratio?

Investors pay $27.6 for every $1 of Viemed Healthcare, Inc.'s yearly profit, higher than 52% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Viemed Healthcare, Inc.: $378 M ÷ $144 M (30 Jun 2026) = 2.6.

What is Viemed Healthcare, Inc.'s return on equity?

Viemed Healthcare, Inc. earned 10.4% on its shareholders' money over the last year, higher than 84% of Healthcare companies in United States.

How much does Viemed Healthcare, Inc. owe compared with what it owns?

Viemed Healthcare, Inc. owes $0.29 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.

Does Viemed Healthcare, Inc. pay a dividend?

No. Viemed Healthcare, Inc. does not currently pay a dividend.

Is Viemed Healthcare, Inc.'s revenue growing?

Revenue rose 21% in the year to Dec 2025, and grew 25% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.